Fill-Finish
Fill-Finish
Fill-finish operations represent the final stage of drug product manufacturing, where drug substance is transformed into its final, patient-ready form. This includes formulation, sterile filtration, aseptic filling into primary containers, inspection, device assembly, and packaging for distribution.
The process begins with blending drug substances and excipients to achieve the required formulation, followed by sterile filtration and transfer to filling systems. Products are filled and sealed under controlled aseptic conditions, then inspected to ensure product and container integrity. Finished units may be assembled into delivery devices such as autoinjectors or syringes before final packaging. Together, these steps ensure safe, consistent, and reliable delivery of high-quality therapies to patients.
Key Issues
Fill-finish operations face critical challenges in maintaining aseptic integrity and minimizing contamination risk throughout processing. The industry is increasingly transitioning toward isolator-based Grade A environments and closed systems to reduce reliance on operator intervention and improve contamination control reliability. Emphasis is placed on maintaining “first air” protection and implementing real-time, in-process controls, including full verification of fill volumes for high-value products. Restricted Access Barrier System (RABs) implantation has been a challenge in cases where isolators have been feasible.
Automation plays a growing role, particularly validated automated visual inspection (AVI) systems capable of detecting defects and fill-weight for small-or high-value batches with high reliability across 100% of the units. Reducing manual interaction, including the adoption of gloveless or minimal-glove isolators, ensures sterility, further enhances process robustness, while supporting consistent product quality and efficient, repeatable operations.
How Fluor Helps
Fluor partners with pharmaceutical manufacturers to deliver highly controlled, efficient, and scalable fill-finish facilities that ensure product sterility and quality. Leveraging deep EPCM expertise, Fluor integrates formulation, sterile filtration, aseptic processing, inspection, device assembly, and packaging within optimized facility designs and workflows.
Fluor applies advanced aseptic technologies, including isolators, restricted-access barrier system, and automation inspection systems, while incorporating robust utilities such as water for injection, clean steam and controlled HVAC environments. By optimizing layouts, minimizing operator intervention, and enabling flexible, multi-product operations, Fluor supports reliable, high-quality production from clinical through commercial manufacturing.
Process Features
Fill-finish operations begin with formulation, where drug substances are combined with excipients in a mixing vessel to achieve the final drug product composition. The solution is sterile filtered, typically through a 0.22-micron filter, and transferred to a holding tank. From there, product passes through a Pre-Use Post-Sterilization Integrity Test (PUPSIT) system and is delivered to filling lines, where containers are aseptically filled and sealed within controlled environments such as isolators or RABs.
Following filling, primary containers undergo inspection to detect particulates, defects, or container integrity issues. Approved units may be assembled into delivery devices such as safety systems, autoinjectors, or pumps. Packaging equipment loads the appropriate container or device into cartons with inserts and completes packaging for shipment. Process support relies on a combination of single-use or clean in place systems, along with consistent utilities and equipment access, ensuring efficient, reliable, and repeatable operations.
Facility Features
Fill-finish facilities are designed to maintain strict control over aseptic processing and product integrity through well-segregated layouts, controlled access and movement, validated handling method with procures that minimize operator intervention, and carefully managed airflow with high-efficiency filtration. HVAC systems play a critical role by maintaining cleanroom classifications, temperatures, humidity and pressure cascades to protect sterile operations.
Reliable operations depend on a comprehensive suite of high-purity and plant utilities. Water for Injection (WFI) supports formulation, equipment rinsing, and final filter flushing before sterile filtration through 0.22-micron filters, helping ensure bioburden and particulate control before filling. Clean steam and nitrogen provide critical sterilization and inerting capabilities. Supporting utilities, including instrument air, vacuum, chilled water, and dependable power, help maintain consistent facility performance. Single-use technologies are supported by controlled storage, assembly, and component management practices that enhance flexibility, reduce cleaning demands, and facilitate efficient multi-product operations.
Fluor Projects
Plasma Fractionation Facility
Location: Japan
Scope: Engineering
Fluor provided concept, basic and detailed design services for two plasma fractionation projects in Japan. Scope included drug substance fractionation and purification, drug product filling, lyophilization, and packaging, supported by utilities and warehouse infrastructure. Designs enable up to 1,000,000 L/year plasma throughput and included LEED and energy conservation assessments that produced recommendations to enhance building efficiency.
Nested Syringe Fill Line Facility
Location: Ireland, Puerto Rico, Colorado, California
Scope: Master Planning, Engineering and Construction Management, Procurement and Construction Management
Fluor has delivered integrated fill-finish solutions for this confidential client for the past two decades starting with late ‘90s across greenfield, brownfield, and retrofit projects, including a 320,000-square-foot parenteral facility (PRFFF) and 15,000-square-foot retrofit expansions (B20 Fill Line). Scope includes aseptic vial, syringe, and cartridge filling, lyophilization, formulation, packaging, and cold chain warehousing, with multiple high-speed filling lines added. Projects addressed live-site execution, integration with upstream supply, and large-scale program delivery, enabling flexible capacity expansion and reliable global biologics supply.
Fill and Finish Expansion
Location: North Carolina, USA
Scope: Engineering
Fluor provided engineering services for this fill-finish expansion, adding approximately 45,000 square feet to increase influenza vaccine formulation and production capacity. The project included new formulation suites, prefilled syringe fill lines, inspection, and packaging capabilities, along with supporting laboratories and utilities. The flexible design enables future expansion while improving operational efficiency and product flow integration.
Parenterals Manufacturing Facility, Therapeutic Protein Pharmaceutical Packaging Facility
Location: Puerto Rico, USA
Scope: Engineering
Fluor provided design and delivery of parenteral manufacturing and packaging facilities, including compounding, vial filling, lyophilization, and finishing operations. The programs incorporated RABS-based aseptic processing, robust utility systems, and scalable layouts to support therapeutic protein production. Designed for flexibility and future expansion, these facilities enable reliable, large-scale injectable drug manufacturing for global markets.
Business Inquiries
Contact Fluor's sales team to learn how Fluor can help you with your business needs and what solutions Fluor offers in your industry. See the buttons below for questions on other topics.